Reilly Financial Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $0 | Buy |
+50
| New | – | ﹤0.01% | 1202 |
|
|
2019
Q4 | – | Sell |
-500
| Closed | -$3K | – | 926 |
|
|
2019
Q3 | $3K | Hold |
500
| – | – | ﹤0.01% | 806 |
|
|
2019
Q2 | $5K | Hold |
500
| – | – | ﹤0.01% | 781 |
|
|
2019
Q1 | $8K | Hold |
500
| – | – | ﹤0.01% | 733 |
|
|
2018
Q4 | $8K | Hold |
500
| – | – | ﹤0.01% | 689 |
|
|
2018
Q3 | $11K | Sell |
500
-4,000
| -89% | -$88K | ﹤0.01% | 678 |
|
|
2018
Q2 | $109K | Hold |
4,500
| – | – | 0.02% | 210 |
|
|
2018
Q1 | $77K | Hold |
4,500
| – | – | 0.01% | 252 |
|
|
2017
Q4 | $85K | Sell |
4,500
-1,000
| -18% | -$18.9K | 0.01% | 259 |
|
|
2017
Q3 | $97K | Hold |
5,500
| – | – | 0.01% | 217 |
|
|
2017
Q2 | $183K | Hold |
5,500
| – | – | 0.03% | 158 |
|
|
2017
Q1 | $176K | Buy |
5,500
+5,000
| +1,000% | +$160K | 0.03% | 157 |
|
|
2016
Q4 | $18K | Sell |
500
-100
| -17% | -$3.6K | ﹤0.01% | 469 |
|
|
2016
Q3 | $28K | Sell |
600
-85
| -12% | -$3.97K | 0.01% | 353 |
|
|
2016
Q2 | $34K | Hold |
685
| – | – | 0.01% | 306 |
|
|
2016
Q1 | $37K | Hold |
685
| – | – | 0.01% | 328 |
|
|
2015
Q4 | $45K | Sell |
685
-600
| -47% | -$39.4K | 0.01% | 308 |
|
|
2015
Q3 | $73K | Buy |
1,285
+85
| +7% | +$4.83K | 0.01% | 314 |
|
|
2015
Q2 | $71K | Sell |
1,200
-400
| -25% | -$23.7K | 0.01% | 358 |
|
|
2015
Q1 | $100K | Hold |
1,600
| – | – | 0.02% | 276 |
|
|
2014
Q4 | $92K | Buy |
1,600
+461
| +40% | +$26.5K | 0.02% | 197 |
|
|
2014
Q3 | $61K | Hold |
1,139
| – | – | 0.01% | 232 |
|
|
2014
Q2 | $61K | Buy |
1,139
+500
| +78% | +$26.8K | 0.01% | 237 |
|
|
2014
Q1 | $34K | Sell |
639
-210
| -25% | -$11.2K | 0.01% | 338 |
|
|
2013
Q4 | $34K | Buy |
849
+80
| +10% | +$3.2K | 0.01% | 310 |
|
|
2013
Q3 | $29K | Sell |
769
-1,716
| -69% | -$64.7K | 0.01% | 295 |
|
|
2013
Q2 | $97K | Buy |
+2,485
| New | +$97K | 0.03% | 143 |
|